Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "CIRC"

267 News Found

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia
Policy | August 09, 2021

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia

Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease


Pfizer and BioNTech expects third dose clinical studies of COVID-19 vaccine in August
News | July 09, 2021

Pfizer and BioNTech expects third dose clinical studies of COVID-19 vaccine in August

The companies anticipate clinical studies to begin in August, subject to regulatory approvals


Honeywell launches solutions to prevent counterfeit pharma products
News | June 23, 2021

Honeywell launches solutions to prevent counterfeit pharma products

The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use


Bharat Biotech ramping up manufacturing capacity to 70 Cr doses: Dr. Raches Ella
People | May 23, 2021

Bharat Biotech ramping up manufacturing capacity to 70 Cr doses: Dr. Raches Ella

We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity


Vaishali Pharma bags order worth US $270,000 from Afghanistan
News | April 26, 2021

Vaishali Pharma bags order worth US $270,000 from Afghanistan

This achievement enables the company to strengthen its presence in the high growth market of South Asian countries


Merck FY20 sales up 8.6% euro 17.5 bn
News | March 04, 2021

Merck FY20 sales up 8.6% euro 17.5 bn

Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.


India approves PLI scheme for pharmaceuticals
News | February 26, 2021

India approves PLI scheme for pharmaceuticals

Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.